MMitraTender

NORFLOXACIN: GeM business opportunity

Who buys NORFLOXACIN on GeM, in which states, how many sellers compete and what wins. Change the filters to match your business.

Live bids: 1Awarded results: 0Live tenders →

What can you do?

GeM categoryNORFLOXACIN
About your business

Live bids + bids closed 2025-11-07 – 2026-11-07 (365 days). Includes imported GeM history.

Live bids
1
Closed in period
8
Awarded results
0
Median winning price (L1)
—
Avg bidders per bid
—

Tenders published per month

Last 12 months, matching your filters

0 Dec 2025
0 Jan 2026
0 Feb 2026
0 Mar 2026
22 Apr 2026
1 May 2026
1 Jun 2026
1 Jul 2026
2 Aug 2026
1 Sept 2026
1 Oct 2026
0 Nov 2026
Show as table
MonthTenders
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20262
May 20261
Jun 20261
Jul 20261
Aug 20262
Sept 20261
Oct 20261
Nov 20260

How open are these bids?

No EMD needed
89%

based on 9 bids

MSE turnover/experience relaxed
0%

based on 1 bids

Reverse auction
0%

based on 9 bids

Turnover, experience, EMD and exemptions come from bid documents and are still sparse; every share shows how many bids it is based on. Results improve as more history is imported.

Top 10: where to work

Ranked by opportunity score (0–100). Open a row to see why.

  1. 1
    NORFLOXACIN73/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    100
    Momentum
    50
    Low competition (not enough data, neutral)
    50
    Easy criteria
    100
    Order value (not enough data, neutral)
    50
  2. 2
    Ceftriaxone54/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    30
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  3. 3
    AMPICILLIN51/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    60
    Momentum
    0
    Low competition (not enough data, neutral)
    50
    Easy criteria
    100
    Order value (not enough data, neutral)
    50
  4. 4
    AMIKACIN39/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    48
    Momentum
    0
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  5. 5
    CEFEPIME39/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    48
    Momentum
    0
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  6. 6
    GENTAMICIN39/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    48
    Momentum
    0
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  7. 7
    OFLOXACIN39/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    48
    Momentum
    0
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  8. 8
    Bromophenol Blue34/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    30
    Momentum
    0
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  9. 9
    Glycine34/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    30
    Momentum
    0
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  10. 10
    Acetocarmine34/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    30
    Momentum
    0
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
Show as table
RankNameScoreLive bidsClosed in periodAvg bidders per bidMedian winning price (L1)
1NORFLOXACIN7318——
2Ceftriaxone5410——
3AMPICILLIN5103——
4AMIKACIN3902——
5CEFEPIME3902——
6GENTAMICIN3902——
7OFLOXACIN3902——
8Bromophenol Blue3401——
9Glycine3401——
10Acetocarmine3401——
How the opportunity score works

Score = Volume 30% + Momentum 20% + Low competition 25% + Easy criteria 15% + Order value 10%. Each part is 0–100; a part without enough data counts as a neutral 50.

  • Volume: tenders in the period, compared with the biggest row of the list.
  • Momentum: share published in the last 30 days vs the average (100 = twice as fast).
  • Low competition: 2 bidders per bid = 100, 15 or more = 0.
  • Easy criteria: share of read bid documents with no EMD, an MSE/startup exemption or no turnover/experience criterion.
  • Order value: median winning (L1) price, compared with the highest in the list.

Who wins these bids

Top L1 sellers in awarded bids of the period

No awarded results for these filters yet.

AI business advisor

Get a short plan from these numbers: where to start, whom to sell to, what to prepare and the risks.